Nanexa AB (publ) (NANEXA.ST)
Nanexa AB (publ) operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Uppsala, UP, SE. The stock last traded at $12.16, up 105.06% on the session, giving a market capitalisation of $2.00B. Its beta of 1.77 implies it has historically moved more than the broad market.
Nanexa AB (publ) is a firm dedicated to developing advanced drug delivery solutions through nanotechnology. The company leverages its proprietary PharmaShell platform, a nanobased system that utilizes atomic layer deposition (ALD) technology for drug administration. Furthermore, Nanexa is progressing NEX-18, a PharmaShell-based candidate specifically designed to address severe conditions such as Myelodysplastic Syndrome and Acute Myeloid Leukemia. The company was established in 2007 and is headquartered in Uppsala, Sweden.
Nanexa AB (publ) is most often compared with the following Healthcare names: